| Title |
Dyslipidemia in patients with chronic kidney disease
|
|---|---|
| Published in |
Reviews in Endocrine and Metabolic Disorders, December 2016
|
| DOI | 10.1007/s11154-016-9402-z |
| Pubmed ID | |
| Authors |
Matthew R. Hager, Archana D. Narla, Lisa R. Tannock |
| Abstract |
Chronic kidney disease (CKD) is associated with high risk for cardiovascular disease (CVD). This association is multifactorial, but CKD is often associated with dyslipidemia, which likely contributes. Patients with CKD have dyslipidemia even at early stages of renal dysfunction and dyslipidemia tends to progress with deterioration of kidney function. The dyslipidemia in CKD is largely due to increased triglyceride levels, decreased HDL-C and varying levels of LDL-C. Current management of CKD may also affect lipid levels. Robust clinical trials demonstrate that statins are safe and efficacious in both lipid lowering and prevention of CVD events in pre-end stage CKD and post-transplant. However, there is no evidence of improved CVD outcomes with statin use in dialysis patients. This review will focus on mechanisms underlying dyslipidemia in CKD and clinical trial evidence for lipid lowering therapy in patients with CKD. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 120 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Netherlands | 1 | <1% |
| Unknown | 119 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 13 | 11% |
| Student > Master | 13 | 11% |
| Student > Bachelor | 13 | 11% |
| Student > Ph. D. Student | 9 | 8% |
| Student > Doctoral Student | 8 | 7% |
| Other | 25 | 21% |
| Unknown | 39 | 33% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 44 | 37% |
| Biochemistry, Genetics and Molecular Biology | 8 | 7% |
| Nursing and Health Professions | 6 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 3% |
| Agricultural and Biological Sciences | 2 | 2% |
| Other | 12 | 10% |
| Unknown | 44 | 37% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 December 2016.
All research outputs
#19,440,618
of 23,911,072 outputs
Outputs from Reviews in Endocrine and Metabolic Disorders
#420
of 505 outputs
Outputs of similar age
#317,704
of 427,095 outputs
Outputs of similar age from Reviews in Endocrine and Metabolic Disorders
#10
of 13 outputs
Altmetric has tracked 23,911,072 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 505 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.5. This one is in the 9th percentile – i.e., 9% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 427,095 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 15th percentile – i.e., 15% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one is in the 7th percentile – i.e., 7% of its contemporaries scored the same or lower than it.